Lexston Mining Yönetim

Yönetim kriter kontrolleri 0/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Jag Bal

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	no data
CEO sahipliği	2.1%
Yönetim ortalama görev süresi	Veri yok
Yönetim Kurulu ortalama görev süresi	Veri yok

Son yönetim güncellemeleri

Recent updates

CEO

Jag Bal (52 yo)

no data

Görev süresi

Mr. Jagdip S. Bal, also known as Jag, serves as President, CEO & Director at Lexston Mining Corporation. He was the Chief Executive Officer and President of Heritage Cannabis Holdings Corporation (formerly...

Lexston Mining Yönetim

Yönetim kriter kontrolleri 0/4

Anahtar bilgiler

Son yönetim güncellemeleri

Lexston Mining Corporation, Annual General Meeting, Dec 30, 2024

President recently sold CA$61k worth of stock

Less than half of directors are independent

Lexston Life Sciences Corp., Annual General Meeting, Nov 08, 2023

No independent directors

Lexston Life Sciences Corp. Announces Resignation of Graeme Staley as Director

Recent updates

Lexston Mining Corporation, Annual General Meeting, Dec 30, 2024

Lexston Mining Corporation Provides Project Update on the ITZA and 176 Uranium Properties in Nunavut

New major risk - Shareholder dilution

New major risk - Share price stability

Lexston Mining Corporation announced that it has received CAD 0.41996 million in funding

New minor risk - Insider selling

President recently sold CA$61k worth of stock

Lexston Mining Corporation Arranges Staking of Additional Mineral Claims in Thelon Basin, Nunavut

Less than half of directors are independent

Lexston Life Sciences Corp., Annual General Meeting, Nov 08, 2023

No independent directors

Lexston Life Sciences Corp. Announces Resignation of Graeme Staley as Director

Lexston Life Sciences Corp. Appoints Clinton Sharples as A Director

Less than half of directors are independent

Lexston Life Sciences Corp. Announces Resignation of Harinder Bains as a Director

Lexston Life Sciences Corp. announced that it has received CAD 0.928122 million in funding

Lexston Life Sciences Corp. Announces the Resignation of Dr. Philippe Henry from His Positions as A Director and the Chief Science Officer of the Company Effective June 15, 2022

Lexston Life Sciences Corp., Annual General Meeting, Aug 11, 2022

Lexston Life Sciences Corp. announced that it expects to receive CAD 0.75 million in funding

No independent directors

Lexston Life Sciences Corp., Annual General Meeting, Jun 17, 2022

Lexston Life Sciences Corp. Initiates Research and Development Project Using Psychedelic Compound 5-Me0-DMT

Lexston Life Sciences Corp. (CNSX:LEXT) acquired Zenalytic Laboratories Ltd. from Avant Brands Inc. (TSX:AVNT) for CAD 0.32 million.

Less than half of directors are independent

CEO

Görev süresi